Drugs / Measles, Mumps and Rubella vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT05254561 Comparator | Nov 2020 → Jun 2021 | — | Zagazig University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles, Mumps and Rubella vaccine | “Measles, Mumps and Rubella vaccine (MMR).” NCT05254561 ↗ |
| Known as | MMR | “Measles, Mumps and Rubella vaccine (MMR).” NCT05254561 ↗ |
| Modality | Vaccine | “Measles, Mumps and Rubella vaccine (MMR).” NCT05254561 ↗ |
| Route | Other | “Injections into the biggest wart” NCT05254561 ↗ |